Serves me right for asking a serious question on an internet board. Some short clown comes in with this type of stupidity. The NYTimes article is irrelevant, GHDX is the gold standard whose thousands of tests have established the company's contribution to the satisfaction of the profession and the government.
The Supreme Court case deals with an issue of great legal subtlety, whether patent law will be used to protect the intellectual property of genomic research. You have nothing to say, so why don't you do all of us a favor and just shut up and spare me the short seller ghost conjuring.